Endralazine in patients with severe hypertension and renal insufficiency.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000974:Antibodies, Antinuclear; D011724:Pyridazines; D014665:Vasodilator Agents; C014926:BQ 22-708